Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

BUY
$3.46 - $5.33 $16,313 - $25,130
4,715 Added 28.32%
21,364 $104,000
Q4 2022

Feb 01, 2023

BUY
$6.26 - $9.34 $23,506 - $35,071
3,755 Added 29.12%
16,649 $127,000
Q1 2022

Apr 21, 2022

SELL
$10.12 - $28.9 $9,624 - $27,483
-951 Reduced 6.87%
12,894 $179,000
Q4 2021

Feb 01, 2022

BUY
$25.17 - $36.85 $83,916 - $122,857
3,334 Added 31.72%
13,845 $388,000
Q3 2021

Nov 15, 2021

BUY
$30.02 - $39.87 $330 - $438
11 Added 0.1%
10,511 $357,000
Q2 2021

Jul 30, 2021

BUY
$32.22 - $44.59 $2,480 - $3,433
77 Added 0.74%
10,500 $429,000
Q1 2021

May 03, 2021

SELL
$37.26 - $67.74 $43,072 - $78,307
-1,156 Reduced 9.98%
10,423 $420,000
Q4 2020

Jan 28, 2021

BUY
$45.01 - $65.47 $147,227 - $214,152
3,271 Added 39.37%
11,579 $685,000
Q2 2020

Jul 28, 2020

BUY
$24.95 - $48.38 $207,284 - $401,941
8,308 New
8,308 $402,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $849M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.